Cargando…
Role of Ureteroscopy (URS) and Stone Treatment in Patients with Recurrent UTIs: Outcomes over a 10-Year Period
Background. The study aimed to assess whether the eradication of kidney stones might result in a substantial reduction in the onset of recurrent UTIs. Methods. We selected all the patients who underwent ureteroscopy (URS) for stone disease between 2012 and 2021, with either a history of recurrent UT...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10219553/ https://www.ncbi.nlm.nih.gov/pubmed/37240697 http://dx.doi.org/10.3390/jcm12103591 |
_version_ | 1785049037159792640 |
---|---|
author | Ripa, Francesco Massella, Virginia Ong, Andrea Mani Sinha, Mriganka Pietropaolo, Amelia Somani, Bhaskar K. |
author_facet | Ripa, Francesco Massella, Virginia Ong, Andrea Mani Sinha, Mriganka Pietropaolo, Amelia Somani, Bhaskar K. |
author_sort | Ripa, Francesco |
collection | PubMed |
description | Background. The study aimed to assess whether the eradication of kidney stones might result in a substantial reduction in the onset of recurrent UTIs. Methods. We selected all the patients who underwent ureteroscopy (URS) for stone disease between 2012 and 2021, with either a history of recurrent UTIs (rUTIs), urosepsis or pre-operative positive urine culture (UC). Data included patient demographics, microbiological data, stone parameters, stone-free and infection-free rates (SFR and IFR, respectively) at follow-up, defined as fragments <2 mm at imaging and the absence of symptoms and urine-culture-proven UTI. Results. Overall, 178 patients were selected. The median age was 62 years. The median cumulative stone size was 10 mm (7–17.25), and the commonest locations were the lower pole (18.9%) and proximal ureter (14.9%). The overall stone-free rate at follow-up was 89.3%. The IFR at 3 months was 88.3%. As follow-up duration increased, the IFR reduced to 85.4%, 74.2%, 68% and 65% at 6, 12, 18 and 24 months, respectively. Patients who had infection recurrence were more likely to present stone persistence or recurrence compared to those who were infection-free at follow-up (20% vs. 4.4%, p = 0.005). Conclusions. SFR after URS is a significant predicting variable for the likelihood of infection-free status at follow-up in patients with an rUTI or positive UC at the time of URS. |
format | Online Article Text |
id | pubmed-10219553 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-102195532023-05-27 Role of Ureteroscopy (URS) and Stone Treatment in Patients with Recurrent UTIs: Outcomes over a 10-Year Period Ripa, Francesco Massella, Virginia Ong, Andrea Mani Sinha, Mriganka Pietropaolo, Amelia Somani, Bhaskar K. J Clin Med Article Background. The study aimed to assess whether the eradication of kidney stones might result in a substantial reduction in the onset of recurrent UTIs. Methods. We selected all the patients who underwent ureteroscopy (URS) for stone disease between 2012 and 2021, with either a history of recurrent UTIs (rUTIs), urosepsis or pre-operative positive urine culture (UC). Data included patient demographics, microbiological data, stone parameters, stone-free and infection-free rates (SFR and IFR, respectively) at follow-up, defined as fragments <2 mm at imaging and the absence of symptoms and urine-culture-proven UTI. Results. Overall, 178 patients were selected. The median age was 62 years. The median cumulative stone size was 10 mm (7–17.25), and the commonest locations were the lower pole (18.9%) and proximal ureter (14.9%). The overall stone-free rate at follow-up was 89.3%. The IFR at 3 months was 88.3%. As follow-up duration increased, the IFR reduced to 85.4%, 74.2%, 68% and 65% at 6, 12, 18 and 24 months, respectively. Patients who had infection recurrence were more likely to present stone persistence or recurrence compared to those who were infection-free at follow-up (20% vs. 4.4%, p = 0.005). Conclusions. SFR after URS is a significant predicting variable for the likelihood of infection-free status at follow-up in patients with an rUTI or positive UC at the time of URS. MDPI 2023-05-22 /pmc/articles/PMC10219553/ /pubmed/37240697 http://dx.doi.org/10.3390/jcm12103591 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Ripa, Francesco Massella, Virginia Ong, Andrea Mani Sinha, Mriganka Pietropaolo, Amelia Somani, Bhaskar K. Role of Ureteroscopy (URS) and Stone Treatment in Patients with Recurrent UTIs: Outcomes over a 10-Year Period |
title | Role of Ureteroscopy (URS) and Stone Treatment in Patients with Recurrent UTIs: Outcomes over a 10-Year Period |
title_full | Role of Ureteroscopy (URS) and Stone Treatment in Patients with Recurrent UTIs: Outcomes over a 10-Year Period |
title_fullStr | Role of Ureteroscopy (URS) and Stone Treatment in Patients with Recurrent UTIs: Outcomes over a 10-Year Period |
title_full_unstemmed | Role of Ureteroscopy (URS) and Stone Treatment in Patients with Recurrent UTIs: Outcomes over a 10-Year Period |
title_short | Role of Ureteroscopy (URS) and Stone Treatment in Patients with Recurrent UTIs: Outcomes over a 10-Year Period |
title_sort | role of ureteroscopy (urs) and stone treatment in patients with recurrent utis: outcomes over a 10-year period |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10219553/ https://www.ncbi.nlm.nih.gov/pubmed/37240697 http://dx.doi.org/10.3390/jcm12103591 |
work_keys_str_mv | AT ripafrancesco roleofureteroscopyursandstonetreatmentinpatientswithrecurrentutisoutcomesovera10yearperiod AT massellavirginia roleofureteroscopyursandstonetreatmentinpatientswithrecurrentutisoutcomesovera10yearperiod AT ongandrea roleofureteroscopyursandstonetreatmentinpatientswithrecurrentutisoutcomesovera10yearperiod AT manisinhamriganka roleofureteroscopyursandstonetreatmentinpatientswithrecurrentutisoutcomesovera10yearperiod AT pietropaoloamelia roleofureteroscopyursandstonetreatmentinpatientswithrecurrentutisoutcomesovera10yearperiod AT somanibhaskark roleofureteroscopyursandstonetreatmentinpatientswithrecurrentutisoutcomesovera10yearperiod |